Glancy Prongay & Murray LLP Continues Investigation on Behalf of Legend Biotech Corporation (LEGN) Investors
October 06, 2020 18:03 ET
|
Glancy Prongay & Murray LLP
LOS ANGELES, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) continues its investigation on behalf of Legend Biotech Corporation (“Legend” or the “Company”) (NASDAQ: LEGN)...